Osaic Holdings
MCRB icon

Osaic Holdings’s Seres Therapeutics MCRB Stock Holding History

Osaic Holdings’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$70 Hold
8
– – ﹤0.01% 7656
2025
Q4 		$119 Hold
8
– – ﹤0.01% 7637
2025
Q3 		$151 Hold
8
– – ﹤0.01% 7720
2025
Q2 		$88 Hold
8
– – ﹤0.01% 7576
2025
Q1 		$112 Sell
8
-12
-60% -$188 ﹤0.01% 7225
2024
Q4 		$335 Sell
20
-75
-79% -$1.22K ﹤0.01% 7098
2024
Q3 		$1.81K Sell
95
-244
-72% -$4.95K ﹤0.01% 6652
2024
Q2 		$4.88K Buy
339
+314
+1,256% +$5.24K ﹤0.01% 6189
2024
Q1 		$389 Sell
25
-20,000
-100% -$431K ﹤0.01% 6867
2023
Q4 		$561K Buy
20,025
+10,308
+106% +$271K ﹤0.01% 3057
2023
Q3 		$462K Buy
9,717
+258
+3% +$19.7K ﹤0.01% 3305
2023
Q2 		$906K Buy
9,459
+9,407
+18,090% +$1.02M ﹤0.01% 2619
2023
Q1 		$5.91K Sell
52
-15
-22% -$1.62K ﹤0.01% 6254
2022
Q4 		$7K Sell
67
-162
-71% -$21.7K ﹤0.01% 6133
2022
Q3 		$29K Buy
229
+177
+340% +$18.1K ﹤0.01% 5320
2022
Q2 		$3K Buy
52
+2
+4% +$172 ﹤0.01% 6734
2022
Q1 		$7K Sell
50
-10
-17% -$1.54K ﹤0.01% 6332
2021
Q4 		$10K Buy
60
+11
+22% +$1.75K ﹤0.01% 6248
2021
Q3 		$7K Sell
49
-30
-38% -$5.87K ﹤0.01% 6389
2021
Q2 		$38K Buy
79
+1
+1% +$422 ﹤0.01% 5243
2021
Q1 		$32K Buy
78
+42
+117% +$19.3K ﹤0.01% 5190
2020
Q4 		$17K Sell
36
-7
-16% -$4.1K ﹤0.01% 5253
2020
Q3 		$24K Sell
43
-487
-92% -$162K ﹤0.01% 4815
2020
Q2 		$51K Hold
530
– – ﹤0.01% 4167
2020
Q1 		$38K Buy
+530
New +$35.5K ﹤0.01% 4194

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Osaic Holdings's MCRB Position: Q1 2026 in Review

Osaic Holdings held its Seres Therapeutics (MCRB) position steady in Q1 2026 at 8 shares worth $70. The position accounts for ﹤0.01% of the portfolio, ranked #7656.

Osaic Holdings first reported a position in MCRB in Q1 2020 and has held it in 25 quarters since. The position peaked at $906K in Q2 2023. 33 funds tracked by Wall St. Rank hold MCRB as of Q1 2026.

  • Osaic Holdings held 8 shares of Seres Therapeutics worth $70 as of Q1 2026.
  • Osaic Holdings left its Seres Therapeutics share count unchanged in Q1 2026.
  • Seres Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7656 holding.
  • Osaic Holdings first reported a position in Seres Therapeutics in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Seres Therapeutics position peaked at $906K in Q2 2023.
  • 33 funds tracked by Wall St. Rank held Seres Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.